CSC acquires majority interest in Danish info tech

Article

Looking beyond the U.S. medical market, healthcare consulting firm Computer Sciences Corporation (CSC) has acquired 60% of the Danish information technology company Scandinavian Healthcare Informatics (ScandiHealth). Because ScandiHealth provides IT

Looking beyond the U.S. medical market, healthcare consulting firm Computer Sciences Corporation (CSC) has acquired 60% of the Danish information technology company Scandinavian Healthcare Informatics (ScandiHealth). Because ScandiHealth provides IT services for the Association of County Councils in Denmark, an organization that acts as spokesperson for all Danish county councils in central government matters such as hospital administration, it proved an attractive buy for CSC. Through this acquisition, CSC assumes responsibility for ScandiHealth's long-term contracts with Danish hospitals and thus will become the largest healthcare IT services provider in Denmark. The firm plans to use the Danish market as a springboard to expand its presence in healthcare in other European countries. Terms of the acquisition were not disclosed.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.